ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Akers Biosciences, Inc.

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Akers Biosciences, Inc. (NASDAQ: AKER) and its board of directors concerning the proposed merger of the company with MyMD Pharmaceuticals, Inc. Akers Biosciences stockholders will own 20% of the combined company. The transaction is expected to close in the first half of 2021.

If you are a stockholder of Akers Biosciences, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/aker/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [e-mail], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-akers-biosciences-inc-301172322.html

SOURCE Rowley Law PLLC

Copyright 2020 PR Newswire